Vaccinations for Hepatitis A and B

Candidates for Hepatitis A Vaccination

Routine Vaccination

  • Children living in areas with high incidence rates of hepatitis A.
  • High-Risk Populations
  • Travelers to developing countries with high rates of hepatitis A, including Mexico
  • Men who have sex with men
  • Users of illegal drugs
  • People who work with hepatitis A virus in research settings
  • People who work with infected nonhuman primates
  • Recipients of clotting factor concentrates
  • People with chronic liver disease (because of risk of fulminant hepatitis A)

Candidates for Hepatitis B Vaccination

  • All infants, children, and adolescents
  • High-Risk Populations
  • People with multiple sex partners and those who have been recently diagnosed with a sexually transmitted disease
  • Sex partners and household contacts of HBV carriers
  • Men who have sex with men
  • Household contacts of adoptees from countries with high rates of hepatitis B
  • Injection drug users
  • Travelers to countries with high rates of hepatitis B (staying longer than 6 months)
  • People with occupational exposure to blood
  • Clients and staff in institutions for the developmentally disabled
  • Patients with chronic kidney failure (including those on chronic hemodialysis)
  • Patients receiving clotting factor concentrates
  • Inmates of long-term correctional facilities

Postexposure Prophylaxis

Prophylactic treatment for exposure to hepatitis B virus involves either hepatitis B immune globulin (HBIG), hepatitis B vaccine, or a combination of both. The HBIG dose equals 0.06 mL/kg. Efficacy ranges from 70 to 95 percent for different types of exposure.

Exposure Treatment
Perinatal 1 dose of HBIG given with the first hepatitis B vaccine dose.
Percutaneous or permucosal HBIG and vaccination depending on vaccination and exposure status.
Sexual HBIG with or without vaccination for exposure to acute hepatitis B; vaccination alone for chronic exposure.
Household contact HBIG with vaccination for acute hepatitis B in infants under age 12 months; vaccination alone for chronic.

Combination Vaccine

There are combination vaccines available that combine vaccinations for hepatitis A and B Los Angeles in one injection. It protects individuals 18 years of age or older against diseases caused by hepatitis A and hepatitis B viruses. The vaccine is recommended for travelers whose occupation or behavior puts them at high risk for exposure to hepatitis B virus, or who are visiting countries with a high or intermediate rate of both hepatitis viruses, as defined by the Centers for Disease Control and Prevention.

Today, gastroenterology conditions can be treated effectively. We provide everyone a personalized gastroenterology treatment plan to meet your unique needs and improve your quality of life. Contact our gastroenterology and hepatology center to schedule a consolation with Los Angeles' preferred Gastroenterologist– Dr. Tabib.


Dr. Tabib's completed his postgraduate fellowship, residency, and internships at the UCLA/Cedar-Sinai Medical Center.

Get your
Consultation Today!

Siamak Tabib, M.D., Inc.
8631 W 3rd St Suite 1015E,
Los Angeles, CA 90048
(310) 652-4472
(310) 358-2266 (Fax)